EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

K Ca channel targeting impairs DNA repair and invasiveness of patient‐derived glioblastoma stem cells in culture and orthotopic mouse xeno grafts which only in part is predictable by K Ca expression levels

Katrin Ganser, Nicolai Stransky, Tayeb Abed, Leticia Quintanilla-Martinez, Irene Gonzalez-Menendez, Ulrike Naumann, Pierre Koch, Marcel Krueger, Peter Ruth, Stephan M Huber iD, Franziska Eckert

International Journal of Cancer · 2024

DOI: 10.1002/ijc.35064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Katrin Ganser und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Neoplasm Invasiveness, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Cancer Aid, Deutsche Forschungsgemeinschaft, Gesellschaft für Kinderkrebsforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prognosis of glioblastoma patients is still poor despite multimodal therapy. The highly brain‐infiltrating growth in concert with a pronounced therapy resistance particularly of mesenchymal glioblastoma stem‐like cells (GSCs) has been proposed to contribute to therapy failure. Recently, we have shown that a mesenchymal‐to‐proneural mRNA signature of patient derived GSC‐enriched (pGSC) cultures associates with in vitro radioresistance and gel invasion. Importantly, this pGSC mRNA signature is prognostic for patients' tumor recurrence pattern and overall survival. Two mesenchymal markers of the mRNA signature encode for IK Ca and BK Ca Ca 2+ ‐activated K + channels. Therefore, we analyzed here the effect of IK Ca ‐ and BK Ca ‐targeting concomitant to (fractionated) irradiation on radioresistance and glioblastoma spreading in pGSC cultures and in pGSC‐derived orthotopic xeno graft glioma mouse models. To this end, in vitro gel invasion, clonogenic survival, in vitro and in vivo residual DNA double strand breaks (DSBs), tumor growth, and brain invasion were assessed in the dependence on tumor irradiation and K + channel targeting. As a result, the IK Ca ‐ and BK Ca ‐blocker TRAM‐34 and paxilline, respectively, increased number of residual DSBs and (numerically) decreased clonogenic survival in some but not in all IK Ca ‐ and BK Ca ‐expressing pGSC cultures, respectively. In addition, BK Ca ‐ but not IK Ca ‐blockade slowed‐down gel invasion in vitro. Moreover, systemic administration of TRAM‐34 or paxilline concomitant to fractionated tumor irradiation increased in the xeno graft model(s) residual number of DSBs and attenuated glioblastoma brain invasion and (numerically) tumor growth. We conclude, that K Ca ‐blockade concomitant to fractionated radiotherapy might be a promising new strategy in glioblastoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNeoplastic Stem CellsNeoplasm InvasivenessBrain NeoplasmsXenograft Model Antitumor AssaysDNA RepairAnimalsHumansMiceCell Line, TumorTumor Cells, CulturedIndolesPyrazoles

Stichwörter der Autor:innen

DNA damage responsegliomaionizing radiationorthotopic xenograft mouse modelpotassium channels

Substanzen

paxillineTRAM 34IndolesPyrazoles

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Hospital of Tübingen, Tübingen, Germany.
  • Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Cluster of Excellence iFIT (EXC 2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard Karls University, Tuebingen, Germany.
  • Molecular Neurooncology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, Tübingen, Germany.
  • Department of Pharmaceutical/Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, Regensburg, Germany.

ORCID-Profile: Stephan M Huber

Förderung

  • German Cancer Aid
  • Deutsche Forschungsgemeinschaft
  • Gesellschaft für Kinderkrebsforschung
  • Deutsche Krebshilfe

Zitieren

APA

Ganser, K., Stransky, N., Abed, T., Quintanilla-Martinez, L., Gonzalez-Menendez, I., Naumann, U., Koch, P., Krueger, M., Ruth, P., Huber, S. M., & Eckert, F. (2024). K Ca channel targeting impairs DNA repair and invasiveness of patient‐derived glioblastoma stem cells in culture and orthotopic mouse xeno grafts which only in part is predictable by K Ca expression levels. International Journal of Cancer. https://doi.org/10.1002/ijc.35064

Vancouver

Ganser K, Stransky N, Abed T, Quintanilla-Martinez L, Gonzalez-Menendez I, Naumann U, et al. K Ca channel targeting impairs DNA repair and invasiveness of patient‐derived glioblastoma stem cells in culture and orthotopic mouse xeno grafts which only in part is predictable by K Ca expression levels. International Journal of Cancer. 2024. doi:10.1002/ijc.35064

BibTeX
@article{Ganser2024,
  author = {Ganser, Katrin and Stransky, Nicolai and Abed, Tayeb and Quintanilla-Martinez, Leticia and Gonzalez-Menendez, Irene and Naumann, Ulrike and Koch, Pierre and Krueger, Marcel and Ruth, Peter and Huber, Stephan M and Eckert, Franziska},
  title = {K Ca channel targeting impairs DNA repair and invasiveness of patient‐derived glioblastoma stem cells in culture and orthotopic mouse xeno grafts which only in part is predictable by K Ca expression levels},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.35064}
}
Kostenlos starten →